×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

NPPA fixes retail prices of 14 formulations

  1340 Views

eMediNexus    03 January 2018

In a notification posted on its website, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 14 formulations under the Drugs (Prices Control) Order, 2013 as below. These include drugs used to treat type 2 diabetes, hypertension, and high cholesterol among others.

  1. Cilnidipine + Metoprolol Tablet
  2. Metformin + Glimepiride + Voglibose Tablets
  3. Rosuvastatin + Clopidogrel Capsule
  4. Telmisartan + Chlorthalidone Tablet (Tigatel CH 80)
  5. Rosuvastatin + Clopidogrel Capsule
  6. Paracetamol+Caffeine+ Phenylephrine+ Diphenhydramine Tablet
  7. Atorvastatin + Clopidogrel Capsule
  8. Atorvastatin + Clopidogrel Capsule
  9. Gliclazide + Metformin Tablet (Glychek M +)
  10. Atorvastatin + Clopidogrel Capsule (Atocor CV 20mg)
  11. Atorvastatin + Clopidogrel Capsule (Avas 20 Gold)
  12. Atorvastatin + Clopidogrel Capsule (Astin 20 Gold)
  13. Rosuvastatin + Clopidogrel Capsule
  14. Rosuvastatin + Clopidogrel Capsule

(NPPA, January 1, 2018)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.